Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Mol Genet Metab ; 123(2): 135-139, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29100779

RESUMEN

Deficiency of ß-Glucocerebrosidase (GBA) activity causes Gaucher Disease (GD). GD can be diagnosed by measuring GBA activity (Beutler and Kuhl, 1990). In this study, we assayed dried blood spots from a cohort (n=528) enriched for GBA mutation carriers (n=78) and GD patients (n=18) using both the tandem mass spectrometry (MS/MS) and fluorescence assays and their respective synthetic substrates. The MS/MS assay differentiated normal controls, which included GBA mutation carriers, from GD patients with no overlap. The fluorescence assay did not always differentiate normal controls including GBA mutation carriers from GD patients and false positives were observed. The MS/MS assay improved specificity compared to the fluorescence assay.


Asunto(s)
Biomarcadores/sangre , Pruebas con Sangre Seca , Fluorescencia , Enfermedad de Gaucher/diagnóstico , Glucosilceramidasa/sangre , Tamizaje Masivo , Espectrometría de Masas en Tándem/métodos , Bioensayo , Recolección de Muestras de Sangre , Estudios de Casos y Controles , Estudios de Cohortes , Enfermedad de Gaucher/metabolismo , Humanos
3.
Clin Chim Acta ; 412(13-14): 1207-12, 2011 Jun 11.
Artículo en Inglés | MEDLINE | ID: mdl-21419758

RESUMEN

BACKGROUND: Fluorometric and tandem mass spectrometry assays can be used to measure lysosomal enzyme activities in dried blood spots (DBS). The effect of DBS preparation, storage and shipping was evaluated on the activities of acid α-glucosidase, acid α-galactosidase, acid ß-glucocerebrosidase, acid sphingomyelinase, and galactocerebrosidase. METHODS: Whole blood from normal donors was used to prepare DBS following Clinical and Laboratory Standards Institute guidelines and by several deviations. Some DBS were subjected to various treatments, storage and shipping conditions. The activity of 5 lysosomal enzymes (GAA, GLA, GBA, ASM, and GALC) was measured using tandem mass spectrometric and fluorometric (GAA only) assays with 2 distinct and commonly used synthetic substrates. RESULTS: Enzyme activities were strongly affected by the way DBS were prepared and stored. Exposure of DBS to elevated heat and humidity can destroy enzyme functions rapidly. DBS prepared from poorly mixed blood caused significant variation on enzyme activities. EDTA, but not heparin, as an anti-coagulant gave more precise results. CONCLUSIONS: The study confirmed the importance of proper and consistent DBS preparation and storage when screening for deficiencies of lysosomal enzymes.


Asunto(s)
Métodos Analíticos de la Preparación de la Muestra/métodos , Recolección de Muestras de Sangre/métodos , Pruebas de Enzimas/métodos , Hidrolasas/sangre , Hidrolasas/metabolismo , Lisosomas/enzimología , Adulto , Métodos Analíticos de la Preparación de la Muestra/instrumentación , Coagulación Sanguínea/efectos de los fármacos , Recolección de Muestras de Sangre/instrumentación , Volumen Sanguíneo , Ácido Edético/farmacología , Pruebas de Enzimas/instrumentación , Filtración , Fluorometría , Heparina/farmacología , Humanos , Papel , Espectrometría de Masas en Tándem , Temperatura
4.
Clin Chim Acta ; 403(1-2): 159-62, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19245803

RESUMEN

BACKGROUND: Fabry disease is an X-linked lysosomal storage disorder due to deficiency of alpha galactosidase A (AGAL, EC 3.2.1.22). Despite increasing utilization of dried blood spot (DBS) as samples for AGAL enzyme assays, the effects of blood sample collection techniques on enzyme activity have not been studied. METHODS: DBS samples were prepared by spotting blood collected into an ethylenediaminetetraacetic acid (EDTA) tube and by direct application of blood from a finger prick or a venipuncture syringe. AGAL activity was measured quantitatively by detecting the fluorescence of 4-methylumbelliferone (4-MU) generated using the substrate 4-methylumbelliferyl-alpha-D-glucopyranoside (4-MUGal) in an acidic pH for 20 h. N-acetyl-D-galactosamine (GalNAc) was used to inhibit alpha-galactosidase B (EC 3.2.1.49). RESULTS: We studied 88 previously diagnosed Fabry disease patients and 690 healthy controls. Average AGAL activity in DBS samples prepared using EDTA tubes was higher compared to those spotted directly irrespective of disease status. CONCLUSIONS: The study confirms the need for collection method-specific reference ranges using DBS samples.


Asunto(s)
Análisis Químico de la Sangre/métodos , Filtración , Papel , Manejo de Especímenes/métodos , alfa-Galactosidasa/sangre , alfa-Galactosidasa/metabolismo , Adulto , Estudios de Casos y Controles , Relación Dosis-Respuesta a Droga , Ácido Edético/farmacología , Enfermedad de Fabry/sangre , Enfermedad de Fabry/enzimología , Femenino , Humanos , Masculino , Reproducibilidad de los Resultados
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA